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Abstract
Background: Cancers are highly heterogeneous
with different subtypes. These subtypes often
possess different genetic variants, present different
pathological phenotypes, and most importantly,
show various clinical outcomes such as varied
prognosis and response to treatment and likelihood
for recurrence and metastasis. Recently, integrative
genomics (or panomics) approaches are often
adopted with the goal of combining multiple types
of omics data to identify integrative biomarkers for
stratification of patients into groups with different
clinical outcomes.
Results: In this paper we present a visual analytic
system called Interactive Genomics Patient
Stratification explorer (iGPSe) which significantly
reduces the computing burden for biomedical
researchers in the process of exploring complicated
integrative genomics data. Our system integrates
unsupervised clustering with graph and parallel sets
visualization and allows direct comparison of
clinical outcomes via survival analysis. Using a
breast cancer dataset obtained from the The
Cancer Genome Atlas (TCGA) project, we are able
to quickly explore different combinations of gene
expression (mRNA) and microRNA features and
identify potential combined markers for survival
prediction.
Conclusions: Visualization plays an important role
in the process of stratifying given population
patients. Visual tools allowed for the selection of
possibly features across various datasets for the
given patient population. We essentially made a
case for visualization for a very important problem
in translational informatics.
Keywords: Molecular Genomic Analysis;
Molecular Biology; Computational Biology
Background
During the past fifteen years, high-throughput ge-
nomic experiments, which involve the usage of micro-
arrays or next generation sequencing technologies,
have significantly changed biomedical research and
clinical practice. These technologies have expedited
the process of discovering genes implicated in im-
portant biological phenomena and molecular mark-
ers for disease. However, for a better understanding
of large high-dimensional data associated with high-
throughput experiments, intuitive visualization tools
are needed in order to effectively interpret the data and
extract new biological knowledge and insights. Specif-
ically, there is an important and unmet need to inte-
grate collected data with previous biological and clin-
ical knowledge. It is thus important to access large
repositories of often structured biological knowledge
and further to have access to interactive tools that
facilitate the required integration and analysis of all
data, especially against the backdrop of prior knowl-
edge. The specific need of integrative visual analytics
is of particular importance given the growing trend of
using integrative genomics (or panomics) approaches
for personalized treatment of diseases, including can-
cer.
Most types of cancers are highly heterogeneous with
different identifiable subtypes. These subtypes often
possess different genetic variants, present different
pathological phenotypes, and most importantly, confer
different clinical outcomes such as varied prognosis and
response to treatment as well as different likelihood
for recurrence and metastasis. Patient stratification is
necessary for prescribing viable regimens of treatment
and also towards the discovery of prognostic and/or
predictive biomarkers.
For instance, there are four main subtypes of breast
cancer: Luminal A (LumA), Luminal B (LumB) and
Triple Negative/Basal-like, and HER2-type. The lumi-
nal subtypes are associated with the expression of es-
trogen receptor (ER) and progesterone receptor (PR),
while HER2-type usually lacks hormone receptor ex-
pression (ie, ER- and PR-) but have amplification
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and/or over-expression of HER2. Basal-like tumors are
commonly described as triple-negative breast cancers
(TNBCs) lacking in expression of hormone receptors
and the oncogene HER2 (HER2-). In order to robustly
characterize patient subtype demographics to achieve
precision medicine, panomics approaches are being in-
creasingly used especially in tandem with the devel-
opment of large collaborative projects such as TCGA
(The Cancer Genome Atlas). In these projects, large
cohorts of patients were recruited and many differ-
ent types of “omics” data including genotypes (e.g.,
single nucleotide polymorphism), copy number vari-
ance, and somatic mutations), gene/microRNA ex-
pression, epigenomics (e.g., DNA methylation), pro-
teomics, pathology images and clinical records as well
as outcome information were collected from these pa-
tients. It is conceivable that by integrating the data
ranging from genotype to multiple levels of pheno-
types, more precise and robust stratification of the pa-
tients with clinical outcome difference can be achieved.
Very least, conflicting stratifications arising from the
consideration of each data collection separately are
avoided, leading to identification of potentially more
robust biomarkers.
However, integrative analysis is a challenging task.
Most of such analysis requires extensive analysis and
development of complicated algorithms such as net-
work integration [1], statistical association and regres-
sion [2], and partial least square analysis [3]. Since
many of the algorithms are still in the development
and testing stage, users are often required to have ex-
tensive preparation in quantitative analysis, algorithm
development and computational methods. These re-
quirements severely hinder the wide utilization of such
data by clinicians and biomedical researchers who are
often only trained in clinical and biological sciences.
Therefore, there is an urgent need for effective tools
that allow biomedical researchers achieve tangible ex-
ploration of patient population using multiple types of
“omics” and patient outcome data.
Here we present a visual analytic system called
interactive Genomics Patient Stratification explorer
(iGPSe), designed to help biomedical researchers to
perform patient stratification on-the-fly and visually
explore disease subtypes in heterogeneous genomic
data. In iGPSe, we employ machine learning algo-
rithms that identify sub-populations based on molecu-
lar feature sets chosen by users. To be effective, iGPSe
relies on an interactive realization of parallel sets and
patient survival plots between selected patient groups.
Thus, investigators are able to quickly examine how a
selected list of molecular features of interest can sep-
arate patients into different groups and whether these
groups show a difference in clinical outcomes. In addi-
tion, iGPSe offers several visualization techniques to
help users evaluate the quality of the stratification
results and thus assess the effects of clustering algo-
rithms. In this work, we demonstrate the use of iG-
PSe on the stratification of breast cancer patients us-
ing both mRNA and microRNA (miRNA) expression
data. The most distinctive feature of iGPSe is a novel
visualization scheme to explore combinations of dif-
ferent data types and identify combined markers for
robust survival prediction of a given population. Ad-
ditionally, iGPSe integrates standard patient stratifi-
cation workflows into an intuitive, user friendly inter-
active platform.
Related work
Cancer tumors that seem very similar when examined
through conventional diagnostic methods might look
different at the molecular level leading to different and
effective outcomes and/or treatment responses. There-
fore, molecular features are being increasingly used
to stratify patients to support more accurate and ro-
bust clinical and therapeutic decisions. Over the past
decade, molecular stratification of tumors using gene
expression microarrays has been an important area of
cancer research [4, 5, 6, 7, 8, 9]. A typical stratifica-
tion study often includes the application of statistical
techniques to population groups including supervised
learning and unsupervised cluster analysis. Heatmaps
have been widely used in many tools [10] to visual-
ize molecular signature patterns manifesting in various
subgroups.
One of the popular genome tools is the UCSC Cancer
Genomics Browser [11]. It allows researchers to iden-
tify and assess genomic signatures in cancer subtypes,
to compare and contrast subtypes, and to assess their
role in stratifying patients into different groups. How-
ever, this ability is restricted to one dataset at a time
and offers no integrative capabilities. Many methods
have been recently reported to discover characteristics
from multiple classes of measurements [12, 13, 14, 15].
These computational methods either build statisti-
cal models [13, 14] or construct multiple networks
or patient samples [15]. In bioinformatics, integra-
tive analysis is becoming more prevalent with the in-
creased adoption of the integrative genomics or the
panomics [16, 17, 18, 19, 20]. A major challenge in
any such integrative study is that the patient popula-
tion is very heterogeneous for any given type of mea-
surement data and thus the ensuing stratifications are
often very different. Integrated visualization of hetero-
geneous data has not received much attention [21, 22].
A salient integrative visualization tool, StratomeX [23],
was proposed towards the visualization and explo-
ration of subtypes in a population afflicted with can-
cer using the TCGA data. StratomeX relies on on the
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Figure 1 Screen shot of the interactive analysis page. On the top left, patient samples are clustered based on both mRNA
expressions (left panel) and miRNA expressions (right panel). Heatmaps of the clustered data are shown aligned with the parallel
sets. On the top right panel, the survival plot shows the patient outcome information and the power of statistical significance
(p-value). On the bottom, force directed graph demonstrates the affinity between patient samples. The patient samples selected in
the parallel sets are circled. The color of the nodes correspond to the ones in the parallel sets.
visual acuity of heatmaps and the discriminative ef-
ficacy of clustering of collected genomics data. It is
however difficult to discover the underlying structure
that exists in a population and pose hypotheses that
compares and contrasts characteristics and outcomes
across sub-populations. Additionally, the high dimen-
sionality of the data makes it difficult to display all of
the relationships in a meaningful manner.
Methods
We developed the visual analytics system iGPSe, a web
based tool facilitating patient stratification and explo-
ration of disease subtypes in heterogeneous genomic
data. We first elaborate the overall requirements of our
system and the underlying design rationale. We con-
tinue by presenting visualization techniques adopted in
iGPSe. We then describe the iGPSe workflow design
and implementation.
Requirements Analysis and Design
In this subsection we outline various design decisions
that ultimately guided our choices for computational
methods and platforms. Our methods share common-
alities with genome wide association studies (GWAS).
To begin with, our studies will require a large popula-
tion of patients. In addition, our collections of datasets
are of multiple modalities (imaging, molecular expres-
sion, etc.), high-dimensional, large, and highly hetero-
geneous. In this section, we first describe input data
under consideration and then enumerate various func-
tionalities that will be required in a typical patient sub-
typing study. Eventually, we will make a strong case
for the use of iGPSe to perform and evaluate patient
stratification.
Data Characteristics
The population data used in iGPSe is extracted from
the TCGA. For our current prototype, we limit our col-
lection to include gene expression (mRNA) and micro-
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RNAs (miRNA) expression. The expression data were
subject to log transformation and normalization fol-
lowing standard bioinformatics practice. Clinical in-
formation includes the age, tumor grade, survival time
and survival status for each patient.
User Wish List for iGPSe
In order to identify the system requirements, we
worked closely with domain experts. The suggestions
and advise collected from our collaborators helped us
to design, implement and improve our system. Accord-
ingly, we identified the following functions, which are
directly based on observations of the domain experts’
standard data analysis workflows.
a) Interactive feature selection: Molecular fea-
tures such as genetic variance and expression levels
for selected genomic regions and genes are often
used as potential biomarkers for identifying cancer
subtypes, which helps in early diagnosis and effec-
tive treatment of cancer patients. Given the nature
of cancer microarray data, which usually consists of
a few hundred samples with thousands of genes as
features, the selection of molecular features is im-
portant for effective gene expression data analysis.
The feature selection step is a commonly addressed
problem in machine learning especially in the con-
text of supervised learning where different subtypes
are labelled with prior domain knowledge. Thus,
one can effectively eliminate the potentially irrel-
evant or obvious features. Users, therefore, should
be able to add/drop/modify features interactively.
Then by examining effects of eventual stratifica-
tion, researchers can verify the quality of the se-
lected feature set and refine it accordingly.
b) Clustering: It is now widely acknowledged that
cancer is biologically heterogeneous. This complex-
ity accounts partly for the variation in clinical out-
come [16]. Given the large variations in genetic and
environmental factors, there is a need to detect sub-
populations and examine them under different an-
notations such as clinical outcome or histological
types. One of the common methods is to cluster the
patient population into subgroups of patients who
share similar expression patterns. However, there
is no one-size-fits-all solution to clustering. Each
algorithm and similarity measurement impose cer-
tain assumptions on the data set. Different clus-
tering algorithms can give widely differing stratifi-
cations, especially when deployed on gene expres-
sion data. Thus, the application should offer mul-
tiple choices of clustering algorithms for the user
to choose. Moreover, the application should allow
users to run clustering on-the-fly, rather than use
precomputed results. In this way, users can choose
the algorithm that works the best on their input
data set and have more control over the stratifica-
tion process. The details of our implementation is
described in Section .
c) Cluster refinement: In many cases, the notion of
a patient subgroups is not well defined in the se-
lected feature space. The stratification of the pop-
ulation is, in most cases, not unique. Moreover, the
number of the viable subgroups is also mostly un-
known. It is important to do an evaluation of how
well an algorithm performs on expression data sets.
The application should provide some clues for the
user to evaluate the quality of the clustering results,
e.g, whether the chosen number of clusters is appro-
priate, the high-similarity within a cluster and the
low-similarity between clusters. Visualization tech-
niques can provide the evaluations. We integrated
three visualization techniques into our system to
help users analyze and improve the clustering re-
sults.
d) Integrated analysis for patient stratification:
Our main goal is to provide various ways to form
combinations of data types interactively. The visu-
alization of these combinations should be intuitive
and easy to navigate. The user must be able to de-
tect patterns in the data through rearrangement
and grouping. Further, he/she must be able to drill
down to interesting details and obtain biological in-
sight. It is also important to include all collected
types of expression data [23]. Clustering results
heavily depend on chosen parameters and differ-
ent types of expression data will give rise to differ-
ent clusters. Consequently the application should
be able to compare stratification results from dif-
ferent data types, which could help researchers an-
swer more complicated questions including whether
there exist dependencies between stratification re-
sults from different data types. It should also of-
fer interactive functions which help the user ex-
plore various combinations of subtypes. In order
to perform the integrative analysis we adopt an in-
teractive visualization method, parallel sets, which
give an intuitive evaluation of the cluster coherence
across different types of expression data and enable
the user to interactively explore the various combi-
nations of clustering. Details of our integrated anal-
ysis are described in Section .
e) Interactive user interface: Interactivity is an
essential requirement given the complex nature of
variation inherent in the datasets and the multitude
of measurements and outcomes. The user needs to
be able interactively to select sub-populations and
clusters and compare outcomes and intrinsic labels
between them. The user interface should be clear
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and intuitive, so that users with no computer sci-
ence background are still able to operate the appli-
cation. Moreover, it should be feasible to customize
certain aspects of the visualization.
Visualization Components
In this section we describe the visualization compo-
nents that are designed to address the aforementioned
requirements. We adopted four visualizations tech-
niques in our system. The heatmap helps users to ex-
amine the expression patterns in clusters. The silhou-
ette plot provides an assessment of the relative qual-
ity of patient clustering. Graph visualization facilitates
the exploration of the overall population in the se-
lected feature space. The parallel sets display enables
users to evaluate cluster coherence between two data
modalities. Moreover, representing sub-populations of
patients in parallel sets allows the user to interactively
visualize the data, as well as to perform statistical tests
to ascertain differences in clinical outcomes.
Figure 2 (a)Heatmaps (b)Silhouette Plot. Both (a) and (b)
are from the same K-means clustering result(k=4)
Heatmap
The heatmap is a popular and intuitive visualization
technique for encoding quantitative measurements. In
the context of gene/microRNA expression data, the
color assigned to a cell in the heatmap grid indicates
expression value of a particular gene in a given pa-
tient sample. The heatmap provides an overview sum-
mary of the data. An example is shown in Figure 2(a);
the given patient population is stratified into four sub-
groups. Each subgroup corresponds to one block of the
heatmap. The height of each block indicates the num-
ber of patients in the corresponding cluster. The main
goal of heatmap in our system is to help the user to ex-
amine gene expression patterns related to the stratifi-
cation. In our example, one can observe that the genes
show distinct patterns between the clusters while the
patterns are consistent within each cluster.
Silhouette plot
Clustering results depends heavily on the parameters
(e.g., the number of clusters) and distribution of the
data points. In order to evaluate the results (and hence
the choice of parameters), we incorporated the silhou-
ette plot [24] into our system. The silhouette plot dis-
plays the degree of certainty of each sample belonging
to its cluster. For our application, this is measured
by the difference of a patient’s average dissimilarity
to other patients of its cluster and the patient’s av-
erage dissimilarity to all patients to the next closest
cluster. The dissimilarity is measured by the squared
Euclidean distance between patients in the selected
feature space. These dissimilarities are standardized
between −1 and 1 and a horizontal bar chart of differ-
ences is plotted for each cluster. Thus the silhouette
plot allows the user to assess the relative quality of the
clusters and provides cues to determine the appropri-
ate number of clusters. Figure 2(b) shows an example
of silhouette plot where the number of clusters is 4.
The blue and purple clusters are relatively tight and
also close to its neighbouring cluster.
Figure 3 Graph Visualization of the patient population
Graph visualization
Graphs have been widely used to capture relationships
among data points. In this work we employ interactive
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graph visualization of similarity matrices to provide a
perspective of the population structure in the feature
space and allow users explore patient population. The
graph is constructed such that each patient is repre-
sented by a vertex, and similarities between patients
are represented by edges connecting these vertices.
Graph visualizations allows one to browse complex re-
lationships and determine community structures. Gen-
erating the graph visualization consists of the following
steps:
a) Similarity Matrix: The similarity matrix reveals
the intrinsic relationships among the entire popu-
lation. Similarity between two vertices (ie, two pa-
tients) can be computed in various ways depending
on the property of the measurement data. In our
application, the user can choose between Pearson’s
correlation and the Euclidean distance, two of the
most commonly used similarity metrics in bioinfor-
matics.
b) Graph Sparsification: The similarity matrix pro-
vides a fully connected graph, which needs to be
pruned down for effective visualization. The goal of
pruning the graph is to extract and summarize the
topology of the underlying feature space. We apply
a global threshold, keeping only those edges with
similarity values exceeding the chosen threshold.
With this approach, the resulting graph captures
the population structure by connecting only highly
similar vertices.
c) Graph Layout and Vertex Labelling: Graph
layout algorithms project N dimensional data onto
two dimensional space for visualization, with the
aim of best preserving actual pairwise distances
between vertices in the original high dimensional
space. We use the force-directed graph layout
method of [25] which was shown to be effective
in creating uncluttered visualizations.
An example of the graph visualization based on the
gene expression features is shown in Figure 3. Since we
use a global threshold to sparsify the graph, there are
a few isolated nodes. The color labelling of the nodes
is consistent with the heatmap and silhouettes plot
(Figure 2). It should be observed that several purple
and blue nodes are densely connected with nodes of
the same color. This confirms our previous observation
made with the use of the silhouette plot (see above).
Parallel Sets
In order to perform the integrative analysis of differ-
ent types expression data we employ the parallel sets
method. Parallel sets enables users to interactively ex-
plore various subgroups obtained as clusters from the
clustering step. For each data type, user-selected fea-
tures (mRNA or microRNAs) are used to separate the
patient population into a number of mutually exclusive
subgroups by a clustering algorithm. Our application
offers k-means, spectral clustering and community de-
tection as choices for the clustering algorithm.
Similar to our setting for the heatmap, in parallel
sets, patient subgroups are represented as columns.
Different types of data are placed independently side-
by-side. In each column, subgroups are encoded by
boxes whose height is proportional to the number of
patients within that subgroup. The color of the boxes
indicates the corresponding subgroups, which is consis-
tent with the node color in the graph visualization for
the same measurement. The ribbons connecting boxes
represent the matching patients in different types of
measurements. The width of the ribbons is propor-
tional to the number of patients. The main goal of
the ribbons is to offer an intuitive view of the consis-
tency of the clustering result between different mea-
surements. A user can combine multiple subgroups
into a larger subgroup by selecting the corresponding
regions.
A user can interactively generate a Kaplan-Meier
plots [27] by selecting subgroups from the parallel sets
visualization. This allows users to evaluate the differ-
ence in clinical outcome between selected subgroups.
In contrast to the purely data-driven approaches, our
application enables the user to treat ribbons as sub-
groups and can interactively combine subgroups from
the clustering algorithm. Thus, a new stratification of
the population based on multiple measurements is now
obtained. An example is shown in Figure 4.
Implementation
In this section, we describe the workflow design of iG-
PSe and discuss how users interact with the system.
Our system workflow has three phases: feature selec-
tion, clustering analysis, and integrative patient strat-
ification.
Our system, iGPSe, is developed in Javascript and
R using the R/Apache module running on an Apache
server. The data processing is implemented with R
script which is triggered by Javascript. The interactive
visualization part is created using d3.js[28], a visual-
ization JavaScript library.
Feature selection
Within the high-dimensional expression data space,
each patient is defined by thousands of genes and hun-
dreds of miRNAs. Inevitably, the data sets contain
noisy or irrelevant genes/miRNAs which makes sub-
typing more complicated. Therefore we need to filter
out irrelevant genes and only focus on the genes in
which the user is interested. iGPSe offers an interac-
tive gene/miRNA list selection panel (Fig. 5). There
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Figure 4 Parallel set visualization and survival analysis panels in iGPSe. Left: The clusters of patients using different feature sets are
shown as bars. On the left side, the blue/yellow/purple/pink bars indicate the four patient groups separated using the PAM50 breast
cancer genes [26]. The gray/green/light blue bars indicate three groups separated using the above discussed miRNAs. The gray
bands linking matched patients. Right: The Kaplan-Meier curves of the survival times for the two groups of selected patients. The
colors of lines matches the colors of the selected bands. In addition, the p-value of the difference in survival times between the two
groups based on log-rank test is also listed (p-value = 3.8173e-06 in this example).
are three ways to input the feature list: 1)users can
select genes/miRNAs of their interest from the table,
or 2) type or copy-and-paste the gene names into the
input areas or 3) upload a text file (comma delimited
format) of the gene list. Once the lists for both genes
and miRNAs features are determined, the following
patient clustering and stratification will only be based
on these selected features. Users can cluster patients
in the next step by clicking the ‘Next’ button.
As shown in the Figure 5, the gene list is ex-
tracted from a recent Nature manuscript describing
the TCGA BRCA (breast cancer) project [29]. It has
been shown that somatic mutations in these three
genes occurred at 10% incidence across all breast can-
cers, which are the highest among all genes. For the
miRNA, we picked hsa-mir-130a, hsa-mir-222, hsa-
mir-29a, hsa-mir-23a,hsa-mir-24-1, hsa-mir-24-2, hsa-
mir-30a, hsa-mir-27a, hsa-mir-22, and hsa-mir-100 as
suggested in [30]. This framework can be easily ex-
tended to accommodate all kinds of commonly used
high throughput molecular data types and signatures.
Clustering analysis
Once the molecular features are selected, iGPSe of-
fers a Clustering section which performs the stratifi-
cation and help users evaluate and refine the cluster-
ing results. The Clustering section provides an inter-
active interface for tuning parameters of clustering al-
gorithms. We provide users three clustering methods:
K-means, spectral clustering, and community detec-
tion.
Following the stratification, iGPSe generates the
heatmap, silhouette plots and population graph visu-
alization to help user evaluate the validity and quality
of the stratification result. iGPSe also provides visu-
alization for an overview of demographic and clinical
information such as patients’ age distribution and tu-
morous grades. A Clustering analysis example for the
TCGA BRCA dataset using afore-mentioned features
is shown in Figure 6.
Integrative patient stratification
Integrative patient stratification section allows users to
review the clustering results and provides an interac-
tive interface to compare clinical outcomes, such as pa-
tient survival and patients ages/tumour grades. Users
can select subgroups from the parallel sets to carry out
survival analysis including Kaplan-Meier curves and a
log-rank test. An example is shown in Figure 1
• Parallel sets view shows clustering results of
patients using different feature sets which are ar-
ranged as columns side-by-side. The columns are
split up into disjoint blocks representing clusters.
Ribbons connect blocks of two columns, whose
width represents how many patients shared be-
tween the two clusters.
• Survival plot view shows the Kaplan-Meier
plots (survival curves) of selected subgroups. If
more than one groups is selected, the p-value
which tests the null hypothesis that the survival
curves are identical in the overall populations us-
ing the log-rank test, will be given. Users can se-
lect the subgroups by clicking the blocks or rib-
bons in the parallel sets view.
• Population graph view provides an interactive
similarity graph visualization. User can drag the
graph to adjust the layout, and select a node to
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Figure 5 Feature selection and input panel in iGPSe. Left:
The user can select list of genes (for mRNA data) from the
left list (extracted from input files) by left clicking on the
genes or input the gene list (e.g., copy and paste) into the
window on the right side. The user can also load gene/miRNA
list from text files. The selected genes will also show up in this
window. Right: The selection and input for miRNA is similar
to that for genes.
acquire correspondence patient’s clinical informa-
tion.
The application also allows users to export the visu-
alization into high quality figures. The users can save a
figure to selected format using the ‘Save Figures’ but-
ton. Currently we support PDF, SVG, JPG, and PNG
formats.
Results
Use Case Studies
We demonstrate the use of iGPSe on a patient cohort
obtained from the TCGA invasive breast carcinoma
Figure 6 The clustering analysis page.
(BRCA) project. The TCGA BRCA dataset contains
623 patients’ mRNA and miRNA expression profiles as
well as clinical outcome information. One of the major
advantages of iGPSe is that it enables the user to select
genes/miRNAs for use as features to study the patient
population.
We are especially interested in the relationship be-
tween a group of cell cycle/genome stability genes and
the well-known mir-17-92 cluster of miRNAs. In a pre-
vious study, we identified a group of more than 400
genes which are frequently co-expressed in multiple
types of cancers but not in normal tissues [31]. This
gene group is highly enriched with genes involved in
cell cycle, mitosis, and genome stability maintenance.
It also includes the well-known breast cancer gene
panel, PAM 50 [26], which purports to possess prog-
nostic capabilities. The mir-17-92 cluster contains a
group of six miRNAs which are proximal on human
chromosome 13 and often co-express. They have been
shown to be involved in the progression of many types
of cancers including lymphoma [32]. Therefore it is of
interest to explore if there is any relationship between
the frequently co-expressed gene and miRNAs groups
in the patient populations and if a combination of them
can lead to better prognosis of the breast cancer pa-
tients.
Since the data has been log transformed we set Eu-
clidean distance as the similarity function in the pre-
view section. By selecting an appropriate threshold
value we get the population graph as in Fig. 1(left
graph is constructed from mRNA, right graph is con-
structed from miRNA). We chose K-means as the clus-
tering method to separate patients mRNA and miRNA
metric into four and three subgroups, respectively.
Figure 1 shows the parallel view and the network
view after the K-means clustering of the patients. In
the graph visualization, one can note that the pop-
ulation stratifications suggested by the mRNA and
miRNA display very different subtyping of patients.
In the mRNA graph, patients in the green and brown
groups are strongly separated from the orange group,
while in the miRNA graph, members in the yellow and
grey groups are relatively mixed.
With iGPSe using the parallel sets in the interactive
visualization stage, we associate the clustering results
with clinical outcomes for the two selected subgroups.
We also compare other subgroups from one or more
data modalities. Figure 7(a) shows the survival analy-
sis for different choice of subgroups from mRNA only
and miRNA only (Figure 7(b)). We can observe that
in both mRNA and miRNA exist one subgroup has
very different survival times than the others. A sim-
ilar observation was reported by others [33, 26]. In-
terestingly, the two patient stratifications are not in-
dependent. The blue cluster in mRNA stratification
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(c) (d)
Figure 7 Comparisons of different choices of subgroups. (a) Compare the blue and yellow/purple/pink groups based only on mRNA
data. (b) Compare the grey/green and light blue groups based only on miRNA data. (c) Two groups with different mRNA profiles
and different miRNA profiles. (d) Two groups with different mRNA profiles but similar miRNA profiles.
is dominated by samples from grey and green clusters
in the miRNA stratification. This observation suggests
that combination of mRNA and miRNA features can
improve the patient stratification. As shown in Fig-
ure 7(c), we can quickly test the choice of other com-
binations and the result shows a much more significant
difference in survival times than just using any single
data type to stratify the patient population.
Users’ Feedback
We collected comments from three domain experts
(Biostatistician, clinician and basic scientist) on the
use of iGPSe, providing some evidence that our visu-
alization and interaction design, grounded in a charac-
terization of the domain requirements, supported effi-
cient explorations of subtypes. We prepared datasets
for the TCGA breast invasive carcinoma (BRCA) co-
horts and invited our domain experts to perform popu-
lation stratification using iGPSe. The initial user feed-
backs on the utility of iGPSe are positive.
Before we present the feedbacks and evaluation de-
tails, we outline typical analysis workflow in genomics
based cancer patient stratification. As we stated ear-
lier, a standard genomic based cancer patient strat-
ification workflow includes steps of data curation
and pre-processing, clustering, subtype characteriza-
tion and validation. Traditionally, these steps involve
scripts written in different platforms which requires
researchers possess at least a basic level of program-
ming skills. Using separate static scripts makes the
analysis of large populations with multiple modalities
laborious, in particular when studying the interactions
between different data types. The design of iGPSe was
directly motivated by these shortcomings and the fol-
lowing observations reflect how domain scientists used
iGPSe to analyze the model described in previous sec-
tion.
• Feature Selection – The identification of dis-
criminant genes is of fundamental and practical
interest. A small subset of highly discriminant
genes can be extracted to build more reliable can-
cer classifiers. For users who do not have experi-
ence in writing scripts to process the input data,
iGPSe interactive GUI offers a more convenient
way than writing scripts to select the target genes
list. A collaborator mentioned that scroll down ta-
ble of genes and input genes can help users adding
and dropping genes from the selected list effec-
tively, especially for people who do not have a
programming background.
• Clustering section – The general aim of the
clustering section is clustering patient population
into subgroups and examine the results’ qual-
ity for each data type. Our collaborators agreed
that the interactive clustering parameters control
panel allows users who have no prior knowledge of
machine learning to guide the stratification pro-
cess. In addition, the graph visualization of the
patient population gives an overview of the popu-
lation density in the selected feature space which
helps users to verify the clustering results are con-
sistent with the proximity graph. The silhouette
plot of the stratification gives a rapid overview of
the quality of the clustering result. This immedi-
ate visual access makes the judgment of simula-
tion output faster and more intuitive. Moreover,
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all views can be compared across runs simply by
launching the visualization multiple times. The
traditional workflow would have forced scientists
to manually run scripts.
• Integrative analysis – our collaborators noted
that parallel set visualization helps them to ex-
plore the relationship between stratification re-
sults from two different types of data. They also
told us that the interactive combination of two
types of data stratification results with the paral-
lel sets is very useful, especially interactively gen-
erating the survival plot. Eventually experts are
able to answer more challenging questions such
as whether patient groups which share similar
gene expression have very different clinical out-
comes when they are expressed differently with
the miRNA.
In general, very positive outcome of the evaluation ses-
sions with our collaborators was that in all cases they
asked us to load further data to explore with iGPSe.
This is convenient especially for testing or replicating
reported gene lists.
Conclusion
Visual analytics is an emerging discipline that com-
bines visualization methods with data analysis and
human-computer interaction. As shown in this pa-
per, application of visual analytics methods in integra-
tive genomics can enable quick integration of different
types of data and significantly facilitate the discovery
of integrated molecular markers for cancer subtyping
and outcome prediction.
In our case study, it is observed that the two groups
of patients with different gene (mRNA) expression pro-
files for the previously identified genome stability genes
show differences in survival times only when they have
similar specific expression profiles for the miRNAs in
the mir-17-92 cluster. This observation suggests that
the genome stability genes and mir-17-92 cluster may
influence breast cancer development and progression
in different pathways even though the genes such as
PAM50 and mir-17-92 cluster interact with each other.
Thus it is of great interest to study the genes and path-
ways targeted by the mir-17-92 clusters in order to
elucidate the different mechanisms.
While we have demonstrated the functionalities of
iGPSe using only mRNA and miRNA signatures,
it nevertheless can accommodate other types of pa-
tient information such as genome-specific information,
DNA methylation, and even morphological features ex-
tracted from pathological images. In addition, the sys-
tem can accommodate comparison among more than
two subgroups as well as more than two types of data,
which makes iGPSe highly versatile for biomedical
researchers to use and generate highly interpretable
results much more promptly than the cumbersome
script-based approach.
Our evaluation with domain experts shows that ma-
jor strengths of iGPSe is that it eliminated the needs of
programming and scripting from users while still grant
users sufficient control during the steps including fea-
ture selection, clustering, subgroup selection and com-
parison. The automatic comparison of clinical outcome
(i.e., survival) is of particular interests to the users.
In the future, we plan to make this a publicly ac-
cessible web tool as it is currently implemented us-
ing an Apache server. Users will be able to upload
and analyze their own data with iGPSe. In addition,
more choices on the clustering algorithms will be im-
plemented. From the machine learning point of view,
our approach provides an alternative way of carrying
out consensus clustering in order to reconcile different
clustering results from different features. This system
can be combined with existing consensus clustering ap-
proaches to further streamline the subgroup selection
process. Since graph visualization allows interactive
manipulation of the data points, a feedback mecha-
nism for interactively assigning clustering membership
based on visualization can be deployed to enable iter-
ative feature selection.
Overall, we have demonstrated that by combining
graph visualization with parallel views and bioinfor-
matics analysis, we can significantly reduce the com-
puting burden for biomedical researchers in order to
explore the complicated integrated genomics data.
This approach is generalizable to enable more sophisti-
cated analysis for cancer biomarker discovery and sub-
typing in order to achieve precision medicine.
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